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Farnesoid X receptor (FXR) is a nuclear receptor protein involved in controlling several 
metabolic pathways, with bile acids as his natural ligands. FXR functions as a sensor for bile 
acids, thus promoting their clearance by controlling expression of genes involved in bile acids 
transport and metabolism. FXR has been recently regarded as an important target for drug 
discovery and the research for small molecules, that modulates his interaction with binding 
co-regulator proteins, is ongoing. Very recently, several reports have shown natural 
compounds and extracts with activity as, either agonists or antagonists of FXR, notably 
steroids (1) and polyphenols (2). Mushrooms have been widely recognised as presenting in 
their chemical constitution polyphenols and steroids in significant amounts, either in quantity 
and diversity.  
For this reason we set out to investigate FXR as a potential target for LMW compounds 
present in mushrooms. To meet this goal we virtually screened a database of 40 compounds, 
present in mushrooms, against a carefully prepared 3D crystal structure of FXR (PDB code: 
1OIV). The molecular docking software used for this virtual screening project was AutoDock 
Vina (VINA) and the database of LMW compounds were revised and prepared by us. VINA 
presents the results as pred∆G (predicted binding energy), with compounds with the lowest 
pred∆G expected to be the ones with more potent FXR modulating activity. 
Among the tested compounds, steroids presented the lowest pred∆G, with several displaying 
values below -10 kcal/mol including: Ergosta-4,6,8(14),22-tetraen-3-one (-10,5 kcal/mol), 
Ganoderic acid A (-10,4 kcal/mol), Ganoderic acid A (-10,3 kcal/mol) and Ergosterol (-10,2 
kcal/mol). These results are not unexpected, as FXR natural ligands are in fact bile acids, that 
belong to the steroid class of compounds. Also, the pred∆G values of the top ranked steroids 
compared well with the pred∆G value of a benzamide derivative compound (10,6 kcal/mol), a 
known inhibitor of FXR that is co-crystallized in the 1OIV crystal structure.  
In conclusion, this initial study points to FXR as a potential target for mushroom compounds 
and extracts, especially steroid derivatives or extracts. Although further studies are needed to 
confirm this hypothesis, this work demonstrates the usefulness of using an in silico approach 
as a complement for experimental work. 
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